SUPPORT for Patients and Communities Reauthorization Act of 2025
- house
- senate
- president
Updated 1 week ago
Last progress December 1, 2025 (4 weeks ago)
This bill makes sure federal health grants about opioids don’t only mention naloxone. It tells the Department of Health and Human Services to treat all FDA-approved or authorized overdose reversal drugs the same in rules and guidance for these grants, not just naloxone. This means programs can use whichever safe, approved medicine works best to quickly reverse an opioid overdose .
It also requires HHS to go back and update older rules and guidance within one year so they include all approved overdose reversal drugs. This applies to major grant programs that support states, Tribes, and prevention efforts focused on substance use disorders .
Last progress July 17, 2025 (5 months ago)
Introduced on July 17, 2025 by John Cornyn
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.